Park, Daehun http://orcid.org/0000-0002-2829-1319
Wu, Yumei http://orcid.org/0000-0003-0878-7605
Wang, Xinbo
Gowrishankar, Swetha http://orcid.org/0000-0002-3043-8703
Baublis, Aaron
De Camilli, Pietro http://orcid.org/0000-0001-9045-0723
Funding for this research was provided by:
National Research Foundation of Korea (2019R1A6A3A03031300)
U.S. Department of Health & Human Services | National Institutes of Health (NS36251, DA018343)
U.S. Department of Health & Human Services | National Institutes of Health
National Parkinson Foundation (PF-RCE-1946)
Article History
Received: 17 July 2022
Accepted: 16 January 2023
First Online: 28 January 2023
Competing interests
: P.D.C. is a member of the Scientific Advisory Board of Casma Therapeutics but declares no competing interest with this study. The other authors have no competing interests.